Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease

Serum soluble Fas (sFas) levels are associated with erythropoietin (Epo) hyporesponsiveness in patients with chronic kidney disease (CKD). Whether sFas could predict the need for erythropoiesis-stimulating agent (ESA) usage and its influence in erythropoiesis remain unclear. We evaluated the relatio...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Physiol Renal Physiol
Hoofdauteurs: Chiloff, Daniela Mendes, de Almeida, Danilo Candido, Dalboni, Maria A., Canziani, Maria Eugênia, George, Sunil K., Morsi, Alshaimaa Mahmoud, El-Akabawy, Nadia, Porada, Christopher D., Durao, Marcelino Souza, Zarjou, Abolfazl, Almeida-Porada, Graca, Goes, Miguel Angelo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Physiological Society 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474254/
https://ncbi.nlm.nih.gov/pubmed/32003597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00433.2019
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items